Table 1 Details of the seven DMD exon deletion cell strains used in this study
From: Breakpoint junction features of seven DMD deletion mutations
Patient ID | Exon deletion | ORF preserved? | Assigned phenotype | Cell type | Origin |
|---|---|---|---|---|---|
d1 | 45–49 | Yes | Becker muscular dystrophy | Myoblast | Dubowitz Neuromuscular Centre, London, United Kingdom |
d2 | 45–47 | Yes | Becker muscular dystrophy | Myoblast | Dubowitz Neuromuscular Centre, London, United Kingdom |
d3 | 45–47 | Yes | Becker muscular dystrophy | Myoblast | Dubowitz Neuromuscular Centre, London, United Kingdom |
d4 | 45–50 | No | Duchenne muscular dystrophy | Fibroblast | The Children’s Hospital at Westmead, Sydney, Australia |
d5 | 46–51 | No | Duchenne muscular dystrophy | Myoblast | Hammersmith Hospital, London, United Kingdom |
d6 | 48–50 | No | Duchenne muscular dystrophy | Myoblast | Dubowitz Neuromuscular Centre, London, United Kingdom |
d7 | 51 | No | Duchenne muscular dystrophy | Fibroblast | Dystrophy Annihilation Research Trust Centre, Bengaluru, India |
